Boston Scientific (BSX) — insider trading
Health Care
Boston Scientific (BSX) has 20 reported SEC Form 4 insider transactions in our data, including 4 open-market purchases among the most recent 20 (latest 2026-07-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | Monson Jonathan | Officer (EVP and CFO) | Option exercise / conversion (derivative) | 2,087 | $0.00 | $0 | Form 4 |
| 2026-07-01 | Monson Jonathan | Officer (EVP and CFO) | Shares withheld for taxes / exercise cost | 1,010 | $43.06 | $43.5K | Form 4 |
| 2026-07-01 | Monson Jonathan | Officer (EVP and CFO) | Option exercise / conversion | 2,087 | $0.00 | $0 | Form 4 |
| 2026-05-28 | Mahoney Michael F | Director, Officer (Chairman, President & CEO) | Bona fide gift | 386,755 | $0.00 | $0 | Form 4 |
| 2026-05-20 | Habiger David C | Director | Open-market purchase | 2,250 | $55.92 | $125.8K | Form 4 |
| 2026-05-20 | LUDWIG EDWARD J | Director | Open-market purchase | 3,580 | $56.68 | $202.9K | Form 4 |
| 2026-05-20 | Pegus Cheryl | Director | Open-market purchase | 1,770 | $56.49 | $100.0K | Form 4 |
| 2026-05-19 | Habiger David C | Director | Open-market purchase | 2,200 | $56.95 | $125.3K | Form 4 |
| 2026-05-07 | Mega Jessica L | Director | Grant / award / vesting | 3,800 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Morano Susan E | Director | Grant / award / vesting | 1,281 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Morano Susan E | Director | Grant / award / vesting | 3,800 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Pegus Cheryl | Director | Grant / award / vesting (derivative) | 1,281 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Pegus Cheryl | Director | Grant / award / vesting (derivative) | 3,800 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Smith Cathy R | Director | Grant / award / vesting (derivative) | 2,209 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Smith Cathy R | Director | Grant / award / vesting (derivative) | 3,800 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Weber Christophe Pierre | Director | Grant / award / vesting (derivative) | 2,660 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Weber Christophe Pierre | Director | Grant / award / vesting | 1,140 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Weber Christophe Pierre | Director | Grant / award / vesting | 1,767 | $0.00 | $0 | Form 4 |
| 2026-05-07 | WICHMANN DAVID S | Director | Grant / award / vesting | 3,800 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Zane Ellen M | Director | Grant / award / vesting | 3,800 | $0.00 | $0 | Form 4 |
Ask the chat about BSX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Boston Scientific (BSX).
Last updated 2026-07-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.